Comment on "<i>PARP-1</i> rs1136410 Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis of Cancer-Type and Ethnic-Specific Associations". [PDF]
Alkan O, Nazli I, Basgoze A.
europepmc +1 more source
Systematic metabolic engineering of <i>Escherichia coli</i> for high-level production of pseudouridine via pathway optimization and precursor enhancement. [PDF]
Song J +6 more
europepmc +1 more source
Structural flexibility of the nicotinamide group of NADH in butanol dehydrogenase YqdH from Fusobacterium nucleatum. [PDF]
Bai X, Nam KH, Xu Y.
europepmc +1 more source
Adenosine A3 Receptor and Its Potential Role in Cancer Treatment: A Narrative Review. [PDF]
Pergolizzi JV, LeQuang JAK, Coleman MH.
europepmc +1 more source
Exploring the optimal cutoff point and genomic characteristics for PARP inhibitor maintenance therapy in early recurrence of ovarian cancer. [PDF]
Ye L +9 more
europepmc +1 more source
Poly(ADP-ribose) (PAR) exhibits ion-dependent structural properties distinct from RNA. [PDF]
Baidya L, Zhang H, Nguyen HT.
europepmc +1 more source
Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by <i>BRCA</i> status: a retrospective cohort study. [PDF]
Zucker K +6 more
europepmc +1 more source
Targeting opportunities presented by the pyrimidine biosynthesis pathway in Mycobacterium tuberculosis: a brief review. [PDF]
Alberti M, Miggiano R.
europepmc +1 more source

